Ton Bolier, MD
Dr. Bolier has been active as a psychiatrist in mental health care for over 20 years. During his medical practice, he became involved in the support and management of startups. Since the late 90’s this has become his primary activity. In December 2009 Dr. Bolier joined the Supervisory Board at Alloksys.
Nandiraju Manohar (Manu) is the CEO of ICM Pharma Pte Ltd., a leading Singapore-based, GMP-certified pharmaceutical manufacturer. Manu has over 14 years experience in senior management roles, providing direction and leadership to fulfil the growth and profitability objectives. Prior to joining the ICM group in Sep 2016, he has served as the Managing Director of Drug Houses of Australia, a Teva group company.
Bert Tournois, PhD
Dr. Tournois Started his professional carreer in the research institute ATO-DLO (1989-2000) where he held various management positions, eventually becoming director of the Business Units Food and Non Food technology. In 2005 he joined the institute directorate as commercial director. In 2000 he founded TDI, a Venture Catalyst Company and since then over 30 startups in medical, agrotechnology and food, including TOP, Holland Food Ventures, Chez Pascal, Ojah, Phycom, Medlogics.
Frans van Duikeren
Frans van Duikeren has a degree in Food Technology (Wageningen UR) and management Consultancy (SIOO). Van Duikeren worked from 1978 until 2003 in the packaging industry, last fifteen years in general management in internationals. From 2004 van Duikeren started a small business consultancy company to support management of starting businesses and SME’s. From 2005 he also acts as an informal investor mainly in life sciences.
Kevin Driscoll, PhD
Dr. Driscoll is an accomplished Healthcare executive with 30 years of experience leading all aspects of innovation and R&D across the prescription drug, OTC drug, and food supplement businesses. He has a strong track record bringing healthcare innovation to market including on brands such as: Actonel; ratiopharm; Prilosec; Vicks; Metamucil; and Swisse Wellness. Dr. Driscoll has built and led global technical organizations, including large multifunctional and virtual start-ups. Most recently he was a founding member of PGT Healthcare, a global JV between Teva Pharmaceuticals and P&G.
Dr. Driscoll has also served as an adviser to industry, government and academia including: Board of Directors for Swiss Precision Diagnostics, BioStart and BioOhio; and, expert adviser to the US EPA, FDA, NASA, UK HSE, IARC and the World Health Organization. Dr. Driscoll holds MS and PhD degrees in Environmental Health Science from New York University and is currently an Adjunct Professor in the Ernest Mario School of Pharmacy at Rutgers University.